Brussels has refused to accept that people in the UK have first claim on Oxford/AstraZeneca doses produced in local plants.
The EU’s health commissioner outright dismissed on Wednesday an argument made by Pascal Soriot, the Anglo-Swedish company’s chief executive, that he was contractually obliged to supply the UK first
